IGI Laboratories, Inc. (IGI) is principally engaged in the development, manufacturing, filling and packaging of topical, semi solid and liquid products for pharmaceutical, cosmeceutical and cosmetic companies. The primary focus of the business is on the commercialization of its licensed Novasome encapsulation technology for skin care/treatment products. The Company licenses the Novasome encapsulation technology from Novavax, Inc. for the applications include animal pharmaceuticals, biologicals and other animal health products; foods, food applications, nutrients and flavorings; cosmetics, consumer products and dermatological over-the-counter and prescription products (excluding certain topically delivered hormones); fragrances, and chemicals, including herbicides, insecticides, pesticides, paints and coatings, photographic chemicals and other specialty chemicals, and the processes for making the same (collectively, the IGI Field).